Health ❯Healthcare ❯Clinical Trials ❯Efficacy Studies

Lecanemab

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs